{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:14:29Z","timestamp":1789528469541,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.seizure.2023.02.015","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T02:18:34Z","timestamp":1676859514000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-4247","authenticated-orcid":false,"given":"Maria","family":"Hoeltzenbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Slimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-348X","authenticated-orcid":false,"given":"Regina","family":"Stegherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-612X","authenticated-orcid":false,"given":"Marlies","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Beyersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Dathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.seizure.2023.02.015_bib0001","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00415-020-09809-0","article-title":"Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective","volume":"268","author":"Toledo","year":"2021","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2023.02.015_bib0002","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"issue":"6","key":"10.1016\/j.seizure.2023.02.015_bib0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(20)30035-1","article-title":"30 years of second-generation antiseizure medications: impact and future perspectives","volume":"19","author":"Perucca","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","article-title":"Using observational cohort data for studying drug effects on pregnancy outcome\u2013methodological considerations","volume":"26","author":"Schaefer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0005","series-title":"European surveillance of congenital anomalies: malformation coding guides","year":"2018"},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2013analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"Meister","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0007","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"2011"},{"issue":"5","key":"10.1016\/j.seizure.2023.02.015_bib0008","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/bimj.201700237","article-title":"Stabilizing cumulative incidence estimation of pregnancy outcome with delayed entries","volume":"61","author":"Rousson","year":"2019","journal-title":"Biom J"},{"issue":"5","key":"10.1016\/j.seizure.2023.02.015_bib0009","first-page":"210","article-title":"[New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany]","volume":"218","author":"Voigt","year":"2014","journal-title":"Z Geburtshilfe Neonatol"},{"issue":"6","key":"10.1016\/j.seizure.2023.02.015_bib0010","first-page":"254","article-title":"[New percentile values for the anthropometric dimensions of twin neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany]","volume":"218","author":"Voigt","year":"2014","journal-title":"Z Geburtshilfe Neonatol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0011","series-title":"A language and environment for statistical computing","year":"2016"},{"issue":"4","key":"10.1016\/j.seizure.2023.02.015_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v038.i04","article-title":"Empirical transition matrix of multi-state models: the ETM package","volume":"38","author":"Allignol","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.seizure.2023.02.015_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864221101687","article-title":"Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide","volume":"15","author":"Nucera","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.seizure.2023.02.015_bib0014","series-title":"Arzneiverordnungs-Report 2021: aktuelle Daten, Kosten, Trends und Kommentare","author":"Ludwig","year":"2021"},{"key":"10.1016\/j.seizure.2023.02.015_bib0015","article-title":"Safety and tolerability of lacosamide in patients with epilepsy: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.seizure.2023.02.015_bib0016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14740338.2020.1713089","article-title":"The adverse-effect profile of lacosamide","volume":"19","author":"Li","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.seizure.2023.02.015_bib0017","unstructured":"European Medicines Agency. Vimpat (lacosamide) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vimpat. Last accessed: 14.11.2022."},{"key":"10.1016\/j.seizure.2023.02.015_bib0018","unstructured":"Food and Drug Administration. Vimpat (lacosamide). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/022253s039,022254s030,022255s022lbl.pdf. Last accessed: 21.11.2022."},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2020.12.005","article-title":"Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE)","volume":"85","author":"Mostacci","year":"2020","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.seizure.2023.02.015_bib0021","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp-2020-323524","article-title":"Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial","volume":"91","author":"Vossler","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.seizure.2023.02.015_bib0022","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000008126","article-title":"Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures","volume":"93","author":"Farkas","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.seizure.2023.02.015_bib0023","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/epi.16381","article-title":"Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy","volume":"60","author":"Ben-Menachem","year":"2019","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2023.02.015_bib0024","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/epi.12085","article-title":"Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers","volume":"54","author":"Cawello","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2023.02.015_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pjnns.2017.03.003","article-title":"Lacosamide during pregnancy and breastfeeding","volume":"51","author":"Lattanzi","year":"2017","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864211037430","article-title":"Efficacy and tolerability of antiseizure drugs","volume":"14","author":"Hakami","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"9","key":"10.1016\/j.seizure.2023.02.015_bib0027","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2023.02.015_bib0028","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.reprotox.2015.07.068","article-title":"Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy","volume":"57","author":"Ylikotila","year":"2015","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2021.03.011","article-title":"Change in the pharmacokinetics of lacosamide before, during, and after pregnancy","volume":"88","author":"Fukushima","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2023.02.015_bib0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1684\/epd.2021.1273","article-title":"Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation","volume":"23","author":"Johannessen Landmark","year":"2021","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2023.02.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108253","article-title":"Lacosamide serum concentrations during pregnancy","volume":"123","author":"Zutshi","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.seizure.2023.02.015_bib0032","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1111\/epi.17395","article-title":"Lacosamide effects on placental carriers of essential compounds in comparison with valproate: studies in perfused human placentas","volume":"63","author":"Berman","year":"2022","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0033","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1038\/s41598-020-64626-9","article-title":"Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice","volume":"10","author":"L\u00f3pez-Escobar","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.seizure.2023.02.015_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/726478","article-title":"Teratogenic potential of antiepileptic drugs in the zebrafish model","volume":"2013","author":"Lee","year":"2013","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.seizure.2023.02.015_bib0035","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00381-016-3181-4","article-title":"Effects of lacosamide \"a novel antiepileptic drug\" in the early stages of chicken embryo development","volume":"32","author":"Mete","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"10.1016\/j.seizure.2023.02.015_bib0036","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/HJH.0000000000001818","article-title":"Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study","volume":"36","author":"Hoeltzenbein","year":"2018","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.seizure.2023.02.015_bib0037","first-page":"e20736","article-title":"Lacosamide-related arrhythmias: a systematic analysis and review of the literature","volume":"13","author":"Yadav","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.25641","article-title":"Therapeutic drug monitoring of newer antiepileptic drugs: a randomized trial for dosage adjustment","volume":"87","author":"Aicua-Rapun","year":"2020","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2023.02.015_bib0039","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.seizure.2023.02.015_bib0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaneurol.2021.5487","article-title":"Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study","volume":"79","author":"Pennell","year":"2022","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2023.02.015_bib0041","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2018.1439595","article-title":"TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians","volume":"19","author":"Schoretsanitis","year":"2018","journal-title":"World J Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.seizure.2023.02.015_bib0042","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"Pt A","key":"10.1016\/j.seizure.2023.02.015_bib0043","article-title":"Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?","volume":"121","author":"Zaccara","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.02.015_bib0044","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2023.02.015_bib0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0733-8619(18)30075-6","article-title":"Pregnancy, teratogenesis, and epilepsy","volume":"12","author":"Yerby","year":"1994","journal-title":"Neurol Clin."},{"issue":"11","key":"10.1016\/j.seizure.2023.02.015_bib0046","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00103-021-03439-1","article-title":"[\"Risk it\"-why women who do not intend to get pregnant do not use contraception: results of the BZgA study \"Women's lives 3. Family planning in women's lives\"]","volume":"64","author":"Helfferich","year":"2021","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"8","key":"10.1016\/j.seizure.2023.02.015_bib0047","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.seizure.2023.02.015_bib0048","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000006173","article-title":"Unintended pregnancy, prenatal care, newborn outcomes, and breastfeeding in women with epilepsy","volume":"91","author":"Johnson","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2023.02.015_bib0049","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.0000000000002791","article-title":"Nonadherence to antiepileptic drugs in Germany: a retrospective, population-based study","volume":"87","author":"Gollwitzer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.02.015_bib0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2021.07.002","article-title":"Zonisamide safety in pregnancy: data from the UK and Ireland epilepsy and pregnancy register","volume":"91","author":"McCluskey","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.02.015_bib0051","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2021.07.030","article-title":"Teratogenic effects of zonisamide","volume":"91","author":"Vajda","year":"2021","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2023.02.015_bib0052","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000000018","article-title":"Association between topiramate and zonisamide use during pregnancy and low birth weight","volume":"123","author":"Hernandez-Diaz","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.seizure.2023.02.015_bib0053","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/epi.16821","article-title":"Perampanel and pregnancy","volume":"62","author":"Vazquez","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.02.015_bib0054","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.04.007","article-title":"Eslicarbazepine acetate exposure in pregnant women with epilepsy","volume":"58","author":"Costa","year":"2018","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2023.02.015_bib0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwm367","article-title":"Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception","volume":"167","author":"Toh","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.seizure.2023.02.015_bib0056","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.reprotox.2016.11.019","article-title":"Who seeks teratology information service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy","volume":"67","author":"Beck","year":"2017","journal-title":"Reprod Toxicol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:04:14Z","timestamp":1761012254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131123000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"alternative-id":["S1059131123000547"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2023.02.015","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2023.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}